Earnings
ARL
17.15
-3.38%
-0.60
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2024
47.32M
47.32M
--
27.06M
20.25M
26.90M
14.62M
--
12.28M
--
0.00
--
-6.64M
13.58M
-23.99M
--
-17.05M
-3.61M
-13.44M
1.26M
--
--
-14.70M
--
-14.70M
--
-14.70M
-14.70M
--
-14.70M
16.15M
-0.91
-0.91
--
0.06
FY 2023
50.50M
50.50M
--
27.90M
22.60M
35.55M
20.20M
--
13.65M
--
1.71M
--
-12.95M
21.58M
-1.92M
--
6.71M
1.46M
5.25M
1.28M
--
--
3.97M
--
3.97M
--
3.97M
3.97M
--
3.97M
16.15M
0.25
0.25
--
0.42
FY 2022
37.54M
37.54M
--
18.34M
19.20M
31.28M
18.79M
--
9.69M
--
2.81M
--
-12.07M
498.37M
87.13M
--
573.42M
98.11M
475.32M
101.97M
--
--
373.35M
--
373.35M
--
373.35M
373.35M
--
373.35M
16.15M
23.11
23.11
--
18.79
FY 2021
42.04M
42.04M
--
20.86M
21.18M
43.25M
29.93M
--
11.87M
--
1.45M
--
-22.07M
2.80M
24.65M
--
5.38M
-1.07M
6.45M
3.10M
--
--
3.35M
--
3.35M
0.00
3.35M
3.35M
--
3.35M
16.15M
0.21
0.21
--
-0.73
FY 2020
59.03M
59.03M
--
24.36M
34.67M
34.78M
20.02M
--
14.76M
--
0.00
--
-112.00K
-25.66M
36.90M
--
11.12M
-147.00K
11.27M
2.24M
--
--
9.03M
--
9.03M
0.00
9.03M
9.03M
--
9.03M
16.05M
0.56
0.56
--
-0.93

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.